Agenus | AGEN - PE Price to Earnings


Agenus reported 17.82 in PE Price to Earnings for its fiscal quarter ending in June of 2022.





Pe Change Date
AbbVie 23.96 0.93 Jun/2026
Amgen 18.07 1.77 Jun/2026
AstraZeneca 25.34 4.25 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
CSL 16.16 9.59 Dec/2025
Eli Lilly 32.9 7.37 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Glaxosmithkline 15.09 3.43 Mar/2026
Incyte 14.45 0.9 Jun/2026
Intrexon 7.54 221.44 Dec/2021
J&J 29.43 4.9 Jun/2026
Jiangsu Hengrui 50.34 3.92 Jun/2026
Merck 17.21 4.47 Jun/2026
Merck 32.26 15.74 Jun/2026
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Novartis 22.41 2.24 Jun/2026
Novavax 2.01 1.07 Dec/2025
Pfizer 11.48 2.16 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Rigel Pharmaceuticals 8.61 8.4 Mar/2025
Veracyte 42.77 17.88 Jun/2026